NBIX — Neurocrine Biosciences, Inc. stock price, charts and financials

QT70Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
166.06
-0.17-0.10%
OverviewShort InterestFilings
NBIXQT70Neurocrine Biosciences, Inc.·NASDAQ
166.06-0.10%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026S-8Registration of employee benefit securities
Jul 31, 202610-QQuarterly report
Jul 31, 20268-K/ACurrent report (amended)
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 09, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
#1 / 25 of 502
Page
▼
/ 21